1. He, Songlin, Gao, Ke, Mao, Long, Bhushan, Sandeep, Xiao, Zongwei. 2020. Gene Silencing of Transcription Factor TEAD4 Inhibits Esophageal Cancer Cells by Regulating TCF7. In Cancer biotherapy & radiopharmaceuticals, 38, 132-139. doi:10.1089/cbr.2020.3870. https://pubmed.ncbi.nlm.nih.gov/32822226/
2. Wang, Ya-Qin, Wu, Dong-Hong, Wei, Denghui, Lv, Jiawei, Chen, Yu-Pei. 2023. TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma. In Science advances, 9, eadd0960. doi:10.1126/sciadv.add0960. https://pubmed.ncbi.nlm.nih.gov/36608137/
3. Chi, Ming, Liu, Jiao, Mei, Chenxue, Meng, Xin, Wang, Biao. 2022. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer. In Journal of experimental & clinical cancer research : CR, 41, 175. doi:10.1186/s13046-022-02377-3. https://pubmed.ncbi.nlm.nih.gov/35581606/
4. Cai, Jingwei, Chen, Tianyi, Jiang, Zhiyu, Xu, Junjie, Cai, Xiujun. 2023. Bulk and single-cell transcriptome profiling reveal extracellular matrix mechanical regulation of lipid metabolism reprograming through YAP/TEAD4/ACADL axis in hepatocellular carcinoma. In International journal of biological sciences, 19, 2114-2131. doi:10.7150/ijbs.82177. https://pubmed.ncbi.nlm.nih.gov/37151879/
5. Gong, Xiaoxia, Li, Ning, Sun, Chen, Li, Zhaoshui, Xie, Hao. 2022. A Four-Gene Prognostic Signature Based on the TEAD4 Differential Expression Predicts Overall Survival and Immune Microenvironment Estimation in Lung Adenocarcinoma. In Frontiers in pharmacology, 13, 874780. doi:10.3389/fphar.2022.874780. https://pubmed.ncbi.nlm.nih.gov/35600867/
6. Emura, Natsuko, Takahashi, Kazuki, Saito, Yuriko, Sawai, Ken. 2019. The necessity of TEAD4 for early development and gene expression involved in differentiation in porcine embryos. In The Journal of reproduction and development, 65, 361-368. doi:10.1262/jrd.2018-120. https://pubmed.ncbi.nlm.nih.gov/31130592/
智鼠故事 
